Skip Navigation



Carcinogenesis Advance Access published online on October 11, 2005

Carcinogenesis, doi:10.1093/carcin/bgi241
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
27/3/619    most recent
bgi241v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Suzuki, R.
Right arrow Articles by Tanaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, R.
Right arrow Articles by Tanaka, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received July 4, 2005
Revised September 11, 2005
Accepted September 30, 2005

CARCINOGENESIS

An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies

Rikako Suzuki 1, Hiroyuki Kohno 2, Masumi Suzui 3, Naoki Yoshimi 3, Hiroyuki Tsuda 4, Keiji Wakabayashi 5, and Takuji Tanaka 2*

1 Department of Oncologic Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan; A Research fellow of the Japan Society for the Promotion of Science, 6 Ichiban-cho, Chiyoda-ku, Tokyo 102-8471, Japan
2 Department of Oncologic Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan
3 Tumor Pathology, University of the Ryukyu Faculty of Medicine, 207 Uehara Nishihara-cho, Okinawa 903-0215, Japan
4 Department of Molecular Toxicology, Nagoya City University, Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
5 Cancer Prevention Basic Research Project, National Cancer Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

* To whom correspondence should be addressed.
Takuji Tanaka, E-mail: takutt{at}kanazawa-med.ac.jp


   Abstract

Oral squamous cell carcinoma is one of the most common human neoplasms, and prevention of this malignancy requires a better understanding of its carcinogenesis process. For this end, we tried to establish an animal model using the human c-Ha-ras proto-oncogene-carrying transgenic (Tg) rats and the carcinogen 4-nitroquinoline 1-oxide (4-NQO). 4-NQO (20 ppm) was administered to Tg and non-Tg rats for 8 weeks in their drinking water, and then the occurrence of tongue carcinogenesis was compared during the experimental period of 22 weeks. In addition, we determined the DNA ploidy in tongue lesions, and examined the immunohistochemical expression of five biomarkers, such as cyclin D1, glutathione S-transferase placental form, cyclooxygenase (COX)-2, inducible nitric oxide synthase (iNOS), and {beta}-catenin. Next, using Tg rats, the cancer chemopreventive effects of nimesulide, pioglitazone, and a synthetic geranylated derivative, which have been reported to be inhibitors of tongue carcinogenesis, were examined in Tg rats treated with 4-NQO. Either during or after treatment with 4-NQO in the drinking water, tongue dysplasia and tumors were observed on the tongues of both Tg and non-Tg rats, with a greater incidence and multiplicity in Tg rats. Histopathologically, squamous cell dysplasia, papilloma, and carcinoma with or without invasion were present in the tongue. Immunohistochemistry revealed that expression levels against five biomarkers increase with disease progression, and the changes correlated with those of the DNA ploidy pattern. Interestingly, a strong expression of COX-2, iNOS, and {beta}-catenin was observed on the invasive front of squamous cell carcinomas. A subsequent chemoprevention study using Tg rats showed that the chemicals tested suppressed the occurrence of tongue carcinomas when they were administered after 4-NQO-exposure. These results may thus indicate that our 4-NQO-induced Tg rat tongue carcinogenesis model simulates many aspects of human oral carcinogenesis and it can be applied for an analysis of oral cancer development while also helping to identify potentially effective cancer chemopreventive agents against oral cancer.

Keywords: Tongue carcinogenesis; Animal model; Human c-Ha-ras proto-oncogene carrying transgenic rats; Immunohistochemistry; Aneuploidy.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
F. Ondrey
Peroxisome Proliferator-Activated Receptor {gamma} Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
Clin. Cancer Res., January 1, 2009; 15(1): 2 - 8.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Miyamoto, Y. Yasui, M. Kim, S. Sugie, A. Murakami, R. Ishigamori-Suzuki, and T. Tanaka
A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies
Carcinogenesis, February 1, 2008; 29(2): 418 - 426.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
T. Ohnishi, K. Fukamachi, Y. Ohshima, X. Jiegou, S. Ueda, M. Iigo, N. Takasuka, A. Naito, K.-i. Fujita, Y. Matsuoka, et al.
Possible Application of Human c-Ha-ras Proto-Oncogene Transgenic Rats in a Medium-Term Bioassay Model for Carcinogens
Toxicol Pathol, April 1, 2007; 35(3): 436 - 443.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.